Flora Growth Corp. (NASDAQ:FLGC – Get Free Report) Director Harold Wolkin acquired 25,000 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was acquired at an average price of $0.97 per share, with a total value of $24,250.00. Following the acquisition, the director now directly owns 25,000 shares of the company’s stock, valued at approximately $24,250. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Flora Growth Price Performance
FLGC opened at $0.97 on Friday. The business has a fifty day moving average price of $1.01 and a 200 day moving average price of $1.27. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.16 and a quick ratio of 0.79. Flora Growth Corp. has a 12 month low of $0.63 and a 12 month high of $2.93.
Flora Growth (NASDAQ:FLGC – Get Free Report) last released its earnings results on Monday, August 12th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.17). Flora Growth had a negative return on equity of 161.06% and a negative net margin of 21.56%. The firm had revenue of $15.68 million for the quarter, compared to analysts’ expectations of $20.74 million. As a group, sell-side analysts anticipate that Flora Growth Corp. will post -0.48 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Get Our Latest Report on Flora Growth
Institutional Investors Weigh In On Flora Growth
A hedge fund recently raised its stake in Flora Growth stock. Renaissance Technologies LLC grew its holdings in shares of Flora Growth Corp. (NASDAQ:FLGC – Free Report) by 105.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 159,595 shares of the company’s stock after buying an additional 81,982 shares during the period. Renaissance Technologies LLC owned 1.19% of Flora Growth worth $163,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 36.01% of the company’s stock.
About Flora Growth
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.
Featured Stories
- Five stocks we like better than Flora Growth
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- How to Calculate Inflation Rate
- MarketBeat Week in Review – 9/9 – 9/13
- Find and Profitably Trade Stocks at 52-Week Lows
- Dividend Stocks to Buy Now for High Yield
Receive News & Ratings for Flora Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flora Growth and related companies with MarketBeat.com's FREE daily email newsletter.